№ files_lp_3_process_7_073812
File format: docx
Character count: 26380
File size: 152 KB
This document outlines the procedure for applying for the MRFF 2022 Quality, Safety, and Effectiveness of Medicine Use and Intervention by Pharmacists grant, including the required steps and eligibility criteria for applicants.
Year:
2022
Region / city:
Australia
Theme:
Medical research, Funding opportunities
Document type:
Application form
Institution:
Department of Industry, Science, Energy and Resources
Author:
Department of Industry, Science, Energy and Resources
Target audience:
Organisations applying for MRFF grant opportunities
Period of validity:
Until 7 September 2022
Approval date:
N/A
Date of amendments:
N/A
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
Insert
Region / City:
Commonwealth of Australia
Subject:
Medical Research and Innovation
Document Type:
Agreement
Organization:
Commonwealth of Australia
Author:
Not specified
Target Audience:
Eligible organisations, participating institutions, chief investigators, and relevant parties involved in MRFF funding
Period of Validity:
Not specified
Approval Date:
Not specified
Amendment Date:
Not specified
Year:
2021
Region / city:
Australia
Theme:
Medical Research, mRNA Clinical Trials
Document Type:
Grant Application Guidelines
Organization / Institution:
Department of Industry, Science, Energy and Resources
Author:
Department of Industry, Science, Energy and Resources
Target Audience:
Researchers, Institutions, Organizations applying for MRFF grants
Period of Validity:
2021-2022
Approval Date:
December 2021
Amendment Date:
None
Program:
MRFF – 2021 mRNA Clinical Trial Enabling Infrastructure
Eligibility Criteria:
State government partner required, Organization must be incorporated in Australia, Entity type selection
Required Documents:
Financial details, ABN, Program selection
Supported Browsers:
Mozilla Firefox, Google Chrome, Microsoft Edge (Windows), Safari, Google Chrome (Mac)
Description:
Online application form for the MRFF 2021 mRNA Clinical Trial Enabling Infrastructure grant opportunity outlining instructions and eligibility criteria for applicants.
Year:
2024
Country:
Australia
City:
Canberra ACT
Programme:
Medical Research Future Fund (MRFF) 2024 National Critical Research Infrastructure Grant Program
Document type:
Approval letter
Issuing body:
Department of Industry, Science and Resources
Address:
GPO Box 2013, Canberra ACT 2601
Signatory role:
Managing Director or Chief Executive Officer
Signatory organisation:
Applicant organisation
Purpose:
Confirmation of organisational support for a grant application and commitment to cover project costs not funded by the grant
Target participants:
Organisations applying for MRFF 2024 National Critical Research Infrastructure funding
Project requirement:
Confirmation that the organisation can complete the proposed project and fund remaining costs if successful
Signature requirement:
Managing Director representing the Board of Management or Chief Executive Officer if no board exists
Year:
2023
Country:
Australia
Topic:
Opioid dependence treatment
Document type:
Information overview
Program:
ODT Community Pharmacy Program
Administering body:
Pharmacy Programs Administrator
Related scheme:
Pharmaceutical Benefits Scheme
Legislative framework:
National Health (Highly specialised drugs program) Special Arrangement 2021
Target audience:
Community pharmacists and hospital pharmacists
Effective date:
1 July 2023
Funding period:
2023–24 to 2026–27
Medicines covered:
Methadone, buprenorphine, buprenorphine with naloxone
Regulatory classification:
Schedule 8 controlled drugs
Source type:
Government health program guidance
Year:
2022/2023
Region / City:
LaSE
Topic:
Trainee Pharmacist Education, Community Pharmacy
Document Type:
Workbook
Organization:
Health Education England (HEE)
Author:
Health Education England (HEE)
Target Audience:
Trainee Pharmacists
Period of Action:
Foundation Training Year 2022/2023
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2021
Region / city:
Victoria, Australia
Theme:
Pharmacist regulations
Document type:
Legislative guideline
Agency / institution:
Medicines and Poisons Regulation (MPR)
Author:
Medicines and Poisons Regulation (MPR)
Target audience:
Health practitioners, pharmacists
Period of validity:
Ongoing
Approval date:
2017
Date of amendments:
2021
Context:
This document provides guidelines for pharmacists regarding the dispensing, administration, and supply of Schedule 4 and 8 medicines in Victoria, Australia, as outlined in the Drugs Poisons and Controlled Substances Act 1981 and related regulations.
Year:
2026
Region / city:
Victoria, Australia
Subject:
Pharmaceutical regulations
Document type:
Legislative guideline
Institution:
Medicines and Poisons Regulation
Author:
Medicines and Poisons Regulation
Target audience:
Pharmacists
Period of validity:
Ongoing
Approval date:
2017
Date of changes:
None specified
Year:
2007
Region / City:
USA
Subject:
Pharmacy Management, Outpatient Care
Document Type:
User Manual
Organization / Institution:
Department of Veterans Affairs (VA)
Author:
Department of Veterans Affairs
Target Audience:
Pharmacists, Healthcare Providers
Period of Validity:
Ongoing Updates
Approval Date:
December 2007
Date of Last Revision:
June 2020
Note:
Context
Year:
2025
Region / City:
Powys
Topic:
Pharmacist responsibilities in transcribing and amending inpatient medication charts
Document Type:
Protocol
Organization:
Powys Teaching Health Board
Author:
Clinical Pharmacist
Target Audience:
Pharmacists employed by Powys Teaching Health Board
Period of Validity:
2025–2028
Approval Date:
14/02/2025
Review Date:
23/02/2028
Date of Changes:
February 2025
Version:
2
Approval Body:
Head of Community Services Pharmacy
Scope:
Powys Teaching Health Board pharmacists
Impact Assessment:
No impact
Training Requirements:
Medicines management team to provide training
Risk Assessment:
No risks identified
Context:
A protocol outlining the procedures for transcribing and amending inpatient medication charts by pharmacists at Powys Teaching Health Board.
Year:
2026
Region / City:
Scotland
Topic:
Clinical portal usage for pharmacists and pharmacy technicians
Document Type:
Instructional Guide
Organization / Institution:
NHS Greater Glasgow and Clyde
Author:
NHS Greater Glasgow and Clyde
Target Audience:
Community pharmacists, pharmacy technicians
Date of Approval:
2026
Date of Changes:
Not specified
Year:
2022
Region / city:
Lagos, Kaduna, Nigeria
Theme:
Family Planning, Health Data Reporting, Mobile Technology
Document Type:
Research Paper
Author:
Osimhen Ubuane, Muhammed Murtala Ibrahim, Emeka Okafor, Sikiru Baruwa
Target Audience:
Health professionals, policymakers, NGOs, private sector actors
Period of validity:
2018–2019
Approval Date:
N/A
Date of amendments:
N/A
Year:
2017
Region / City:
Victoria
Topic:
Pharmaceutical Regulations
Document Type:
Official guidelines
Institution:
Medicines and Poisons Regulation
Author:
Unknown
Target Audience:
Health practitioners, pharmacists
Effective Period:
Ongoing
Approval Date:
2017
Amendment Date:
Not specified
Year:
2023
Region / City:
Islamabad
Subject:
Attestation procedures for medical professionals and related certifications
Document Type:
Standard Operating Procedure
Organization:
Ministry of National Health Services, Regulations & Coordination (M/o NHSR&C)
Author:
Not specified
Target Audience:
Medical professionals and administrative personnel involved in attestation processes
Validity Period:
Not specified
Approval Date:
Not specified
Amendment Date:
Not specified
Description:
Procedure for attestation and issuance of NOC/Letter of Need for doctors, nurses, paramedics, pharmacists, homeopaths, and physiotherapists, detailing the required documents and verification processes for each profession.
Organisation:
PillBox Chemists Ltd
Document type:
Declaration and terms and conditions form
Subject:
Fitness to practice, booking conditions, and professional obligations of locum pharmacists
Intended audience:
Locum pharmacists
Regulatory framework:
General Pharmaceutical Council standards and NHS England requirements
Geographical scope:
United Kingdom
Required submission time:
At least 2 days prior to booking, or on arrival for emergency bookings
Accreditation areas:
Repeat Dispensing, Safeguarding Level 2, MURs, NMS, EPS, SCR, Seasonal Flu Vaccination
Compliance areas:
Clinical governance, standard operating procedures, ordering policies, time keeping, pharmacy services
Declaration elements:
Fitness to practice, DBS self-declaration, indemnity insurance, disciplinary history
Contact method:
Email and fax submission to company bookings office
Year:
2023
Region / city:
[insert local health board name]
Topic:
Healthcare / Pharmacy
Document type:
Patient Group Direction
Organisation / institution:
NHS Wales
Author:
Alya Al-Affan
Target audience:
Registered community pharmacists
Period of validity:
1st July 2023 - 31st March 2026
Approval date:
20th June 2023
Change history:
Version 1.0 developed on 9th February 2023
Expiry date:
30th June 2026
Year:
2025
Region / City:
United States
Subject:
Pharmacy, Education, Scholarships
Document Type:
Scholarship Program Information
Organization / Institution:
CVS Health, AACP
Author:
CVS Health, AACP
Target Audience:
Student Pharmacists
Eligibility Period:
2025-26 Academic Year
Approval Date:
N/A
Modification Date:
N/A
Year:
2025
Region / City:
England
Topic:
Emergency contraception
Document type:
Patient Group Direction (PGD)
Organization / Institution:
NHS England
Author:
Dr Cindy Farmer, Michelle Jenkins, Vicky Garner, Gail Rowley, Julia Hogan, Kate Devonport, Chetna Parmar, Helen Donovan, Carmel Lloyd, Clare Livingstone, Kirsty Armstrong, Dipti Patel, Emma Anderson, Dr Kathy French, Dr Sarah Pillai, Alison Crompton, Andrea Smith, Lisa Knight, Bola Sotubo, Tracy Rogers, Sandra Wolper, Jo Jenkins
Target audience:
Pharmacists, Pharmacy Technicians
Effective period:
June 2025 - February 2026
Approval date:
November 2022
Review date:
September 2025
Expiry date:
February 28, 2026
Year:
2015
Region / city:
Republic of Moldova
Theme:
Financial Audit
Document Type:
Audit Report
Organization / institution:
Court of Accounts of the Republic of Moldova
Author:
Court of Accounts of the Republic of Moldova
Target audience:
Parliament and Government of the Republic of Moldova, World Bank, Ministry of Labor, Social Protection and Family, and other stakeholders
Period of validity:
2015
Approval date:
2016
Date of changes:
-
Year:
2024
Region / city:
New Zealand
Topic:
Wage subsidy programs, Employment assistance
Document type:
Research report
Organization / institution:
Ministry of Social Development
Author:
Marc de Boer
Target audience:
Policymakers, researchers, social service providers
Period of validity:
2013-2023
Approval date:
May 2025
Date of revisions:
Not specified